SlideShare a Scribd company logo
PRESENTER—
HABIBUR RAHAMAN
CHAIRPERSON—
DR.PIJUSH KANTI BISWAS,Assistant
Prof
 In systemic disease ,invovlement of multiple
organs is the general rule.Yet cardiac
involvement in many systemic diseses is not
well recognise ,as the dominant manifestation
frequently reside in other organ systems.Cardiac
involvement is very common with many
systemic disease and may account for serious
morbidity or mortality.Early recognisation of
cardiac involvement may impact upon patient
management and prognosis.
• Pericarditis -is the most commonly
recognized cardiac problem[30%].Pericardial
effusion
Myocarditis –common histologically but
seldom present as HF unless hypertensive.It
is parallel to disease activity.
Endocarditis—Fibrinous Libman Sacks
endocarditis,lesion may cause embolic
events or infected but rarely cause
haemodynamically important regurgitation.
Vascular –occlusive events as MI,CVA,TIA
increase(3 TO 10 fold).More common if
APLA.
• MI—due to primarily accelerated
atherosclerosis.
• Riskfactors for accelerated atherosclerosis
include old age,HTN,Dyslipidemia,Repeated
high score disease activity, diseaseduration,
high total or daily dose of
glucocorticoids,postmenopausal statusand
high homocysteine.
• Babies born to mothers with SLEand havean
increased incidence of congenital completeAV
block.
• Unexplained recurrent venous or arterial
thrombosis, or frequent secondor third trimester
miscarriages.
• Venous thrombosis –Superficial and DVT,cerebral
vein throbosis,pulmonary embolism& HTN,retinal vein
thrombosis.
• Arterial thrombosis—stroke,TIA,MI(10%).cardiac
valve involvement or dysfunction(14%),upper and
lower extremities leg ulcer ,digital gangrene and
many more
• Heart valve leaflet thickening, thrombotic masses
extendingfrom the valve ring or leaflets, or
vegetations.
 Cardiac involvement often silent in SSc
frequently detected when screened with
sensitive tools as TDE,cMRI,thalium screening.
Evident cardiac involvement –poor prognosis.
May involve all layer ,manifest as acute
pericarditis ,pericardial effusion, constrictive
pericarditis, heart block or arrthymia
,ventricular dysfunction to overt HF.
• Ventricular conduction abnormalities are
common and, along with a septal pseudo-infarct
pattern (q wave inversion in ecg mimic mi due to
elongation and partial stretching of cardiac nerve
fibres) , correlate with reduced myocardial
function with exercise
• Cardiac involve more in dcSSc than lcSSc
and generally develop within 3yrs of
onset of skin thickening
• Most common form of chronicinflammatory
polyarthritis.can involve any layers of
heart.
PERICARDIUM-Pericarditis-pericardial effusion(10-
40%),EXUDATIVE- Decrease Complement.
• MYOCARDIUM-Rare,CMPdueto
necrotising myocarditis.
• ENDOCARDIUM-Coronaryarteritis,intimal
inflammation present 20%,rarelymanifest.
• Valveinvolvement—duetogranuloma,mitral
andaorticvalve,MR
 Associated with pancarditis and proximal
AORTITIS.
 Aortic involvement mainly in aortic root but
may extent upto aortic and mitral
valve,ventricular myocardium.
 1/10 significant AR and 1/3 present with
conduction block (even CHB)
 AR may precedes onset of arthritis ,SO DX OF
SERONEGETIVE ARTHRITIS SHOULD BE
CONSIDERED IN YOUNG MALE WITH
ISOLATED AR
• Granulomatous inflammatory diseaseof
unknown cause.
• Pericarditis though uncommon –usually
clinically insignificant
• Granulomatous infiltrative diseaseof the
myocardium is often asymptomatic, but can
causearrhythmias, conduction diseaseand,
rarely, otherwise unexplained congestive
heart failure
• Pulmonary artery hypertension and cor
pulmonale canoccur in sarcoidosis,generally
asaresult of pulmonary fibrosis.
• Systemicvasculitis - anuncommon
complication of sarcoidosis.
• Sarcoidvasculitis canaffect small- to large-
caliber vessels,including the aorta.
CAD is the most common causeof death in
adults with DM.
• DM, is an independent risk factor for CAD
and accounts for 14–50% of new casesof
cardiovasculardisease.
• Pathogenesis-
• endothelial dysfunction
• increased lipoprotein peroxidation
• increased inflammation,
• aprothrombotic state,
• associated metabolic abnormalities.
Diabetic patients aremore likely to have
MI ,greater burden of CAD,
larger infarct size,
more post infarct complications( HF, shock,death).
•.“SILENT ISCHEMIA,”resulting from ANS
dysfunction, accounting for up to 90%of their
ischemic events.
•ATYPICALischemic symptoms-
nausea,dyspnea,arrthymias,pulmonaryedema,heart
block,syncope—ANGINALEquivalent
Patients with DM also may have
• Abnormal LV systolic anddiastolic function,
reflecting concomitant hypertension,
Coronary microvascular disease,
• Endothelial dysfunction,
• Ventricular hypertrophy,
• Autonomic dysfunction.
• Restrictive cardiomyopathy
• INSULIN THERAPY MAY DECREASE
OVERALL MYOCARDIAL DYSFUNCTION.
 Bp is altered across the entire spectrum thyroid
function.
 HYPERTHYROID ISM:-
Widened pulse pressure
arterial stiffness ISOLATED SYS HTN
low systemic VR
HYPOTHYROIDISM:-
Endothelial dysfunction
Impaired VSM relaxation Diastolic HTN
 INCREASES in
– heart rate
– cardiac contractility,
– systolic and mean pulmonary artery pressure,
– cardiac output, diastolic relaxation, and
– myocardial oxygen consumption
 REDUCTIONS in
– systemic vascular resistance and
– diastolic pressure
Tachycardia, at rest, during sleep, and
exaggerated
during exercise.
• Palpitations – tachy/forceful cardiac
contractility
• Hyperdynamic precordium.
• Systolic hypertension with widened pulse
pressure
• Exertional dyspnea, which is due to respiratory
and skeletal muscle weakness
• Uncommon heart murmur which occurs in
patients with hyperthyroidism.
• It is a mid-systolic scratching sound best heard
over the second left intercostal space at the end of
expiration.
• Results from the rubbing of
the pericardium against the pleura in the context
of hyperdynamic circulation and tachycardia,
• Mimic the sound of a pericardial rub.
 Major cardiovascular changes
– decrease in cardiac output
– decrease in cardiac contractility
– reduction in heart rate
– increase in peripheral vascular resistance.
 • Others
– Hypercholesterolemia ,
– diastolic hypertension,
carotid intimal media thickness
• Exertional dyspnea
• Cardiac dysfunction with poor contractility.
• Bradycardia.
Pericardial effusions, in approximately 25% of patients
and may be quite large.
•Increased systemic capillary permeability and
disturbances in electrolyte metabolism.
• characterized by a high protein and cholesterol content.
 – Hypercholesterolemia
 – Diastolic hypertension, and
 – Elevated homocysteine levels
 – Elevated C-reactive protein and
 – Endothelial dysfunction
• Patients with angina pectoris probably have
less symptoms as they are less active and
peripheral oxygen demands decrease.
• Exposureof the heart toexcessivegrowth hormone
may causeCHFasaresult of high cardiac output,
diastolic dysfunction owing to ventricular
hypertrophy global systolicdysfunction.
• Hypertension occurs in up to one-third of patients
with acromegaly and is characterized by
suppression of the renin-angiotensin-aldosterone
axisand increases in total-body sodium andplasma
volume.
• Some form of cardiac disease occurs in about one-
third of patients with acromegaly and is associated
with adoubling of the risk of cardiac death.
• In addition to causing labile or sustained
hypertension, the high circulating levels of
catecholamines resulting from a
pheochromocytoma may causedirect myocardial
injury.
• Focalmyocardial necrosis and inflammatory cell
infiltration are present in ~50%of patients whodie
with pheochromocytoma and may contribute to
clinically significant left ventricular failure and
pulmonary edema.
• Left ventricular dysfunction and CHFmay resolve
after removal of thetumor.
 The pulseless disease or occlusive
thromboaortopathy.
 Aneurysm most common and clinically
most significant in aortic root where
they can lead to valvular
regurgitation(aprox 20%)
• Causeof GCAremains unknown, the
inflammatory lesion begins in theadventitia.
• Most characteristic features of GCAare new
onset of atypical and often severe headaches,
scalp and temporal artery tenderness, acute
visual loss, polymyalgia rheumatica, and painin
the muscles of mastication.
• GCAmay produce clinically apparent aortitisin
~15%of casesand involve the primarybranches
of the aorta, especially thesubclavian arteries,
• Raresyndrome that includes ahistory of asthma,
eosinophilia, pulmonary infiltrates, upper airway
inflammation, and avariable frequency of renal,
neurological, cutaneous, and cardiac
involvement.
• Cardiacdiseasein CSSis the most commoncause
of death. It is reported in 15 to 55 percent of
casesand may include pericarditis, myocarditis,
and coronary arteritis. Congestive heart failure
occurs in 15 to 30 percent ofcases.
• Nongranulomatous disease of onlymedium-
sized arteries.
• Necrotizing changesseen, with weakening of
the vesselwall and aneurysm formation or
myointimal proliferation, causingstenosisand
occlusion.
• cardiac disease(10 to 30 percent; congestive
failure, angina, infarction, pericarditis)
hypertension (approximately 30 percent)
• Acute febrile systemic illness of childhood.
• Cardiacabnormalities - pericardial effusions (~30
%),myocarditis, mitral regurgitation (~ 30 %),
aortitis and aortic regurgitation (infrequent),
congestive heart failure, and atrial andventricular
arrhythmias.
• Deaths usually result from acute coronaryartery
thrombosis in aneurysms that form following
vasculitis.
• Thiamine deficiency hasbeen found in 20–90% of
patients with chronic heart failure. This deficiency
appears to result from both reduced dietary intake
and adiuretic-induced increase in the urinary
excretion ofthiamine.
• The acute administration of thiamine to these
patients increases the left ventricular ejection
fraction and the excretion of saltand water.
• The classic associated cardiovascular syndrome is
characterized by high-output heart failure,
tachycardia, and often elevated biventricular filling
pressures
• In patients whose intake of protein,calories,
or both is severely deficient, the heart may
become thin, pale, and hypokinetic with
myofibrillar atrophy and interstitial edema.
• Generalized edema is common and relates to
a variety of factors, including reduced serum
oncotic pressure and myocardialdysfunction.
• Open-heart surgery posesincreased risk in
malnourished patients.
• 50%of patients with carcinoid syndrome
havecardiac involvement, usually manifesting
asabnormalities of the tricuspid or pulmonic
valves.
• Carcinoid heart diseasemost often presents
as tricuspid regurgitation, pulmonic stenosis,
or both. In some cases,ahigh cardiac output
state may occur, presumably asaresult of a
decrease in systemic vascular resistance
resulting from vasoactive substancesreleased
by the tumor
• Obesity is associated with an increased
prevalence of hypertension, glucose
intolerance, atherosclerotic CAD,atrial
fibrillation, obstructive sleep apnea, and
pulmonary hypertension, and is associated
with increased cardiovascular morbidity and
mortality rates.
• In addition, obesepatients haveadistinct
hemodynamic profile characterized by
increased total and central bloodvolumes,
increased cardiac output, and elevatedleft
ventricular filling pressure
• In part asaresult of chronic volume overload,
eccentric cardiac hypertrophy with cardiac dilation
and ventricular diastolic and/or systolicdysfunction
may develop.
• In addition, altered levels of adipokines secretedby
adipose tissue may contribute to adverse
myocardial remodeling via direct effects on cardiac
myocytes and other cells.
Cardiac manifestation of systemic disease.pptx final
Cardiac manifestation of systemic disease.pptx final

More Related Content

What's hot

Heart failure (what a family physician need to know)
Heart failure (what a family physician need to know)Heart failure (what a family physician need to know)
Heart failure (what a family physician need to know)
Ahmed Abouelela
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
Sunil Reddy D
 
Mitral regurgitation
Mitral regurgitationMitral regurgitation
Mitral regurgitation
Ramachandra Barik
 
Takayasu's arteritis
Takayasu's arteritisTakayasu's arteritis
Takayasu's arteritis
Ankur Gupta
 
Congenital heart diseases in adults
Congenital heart diseases in adults Congenital heart diseases in adults
Congenital heart diseases in adults
anoop k r
 
Dilated cardiomyopathy
Dilated cardiomyopathyDilated cardiomyopathy
Dilated cardiomyopathy
Lazoi Lifecare Private Limited
 
Constrictive pericarditis
Constrictive pericarditis Constrictive pericarditis
Constrictive pericarditis
Ramachandra Barik
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathies
Abhay Mange
 
Chronic coronary syndromes
Chronic coronary syndromesChronic coronary syndromes
Chronic coronary syndromes
Yousra Ghzally
 
Mi
MiMi
Pericarditis
PericarditisPericarditis
Pericarditis
Sakina Musa
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
Yogesh Shilimkar
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
Rawalpindi Medical College
 
Myocarditis by Shipra Shekhar
Myocarditis by Shipra ShekharMyocarditis by Shipra Shekhar
Myocarditis by Shipra Shekhar
Shipra Shekhar
 
Takotsubo cardiomyopathy
Takotsubo cardiomyopathyTakotsubo cardiomyopathy
Takotsubo cardiomyopathy
Sudeb Mukherjee
 
Mitral valve stenosis
Mitral valve stenosisMitral valve stenosis
Mitral valve stenosis
Vutriloc
 
Echocardiography in ischemic heart disease
Echocardiography in ischemic heart diseaseEchocardiography in ischemic heart disease
Echocardiography in ischemic heart disease
Bhargav Kiran
 
Conduction Disorders
Conduction DisordersConduction Disorders
Conduction Disorders
Eneutron
 
Constrictive Pericarditis
Constrictive PericarditisConstrictive Pericarditis
Constrictive Pericarditis
Rashid Abuelhassan
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated Cardiomyopathy
Nizam Uddin
 

What's hot (20)

Heart failure (what a family physician need to know)
Heart failure (what a family physician need to know)Heart failure (what a family physician need to know)
Heart failure (what a family physician need to know)
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
 
Mitral regurgitation
Mitral regurgitationMitral regurgitation
Mitral regurgitation
 
Takayasu's arteritis
Takayasu's arteritisTakayasu's arteritis
Takayasu's arteritis
 
Congenital heart diseases in adults
Congenital heart diseases in adults Congenital heart diseases in adults
Congenital heart diseases in adults
 
Dilated cardiomyopathy
Dilated cardiomyopathyDilated cardiomyopathy
Dilated cardiomyopathy
 
Constrictive pericarditis
Constrictive pericarditis Constrictive pericarditis
Constrictive pericarditis
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathies
 
Chronic coronary syndromes
Chronic coronary syndromesChronic coronary syndromes
Chronic coronary syndromes
 
Mi
MiMi
Mi
 
Pericarditis
PericarditisPericarditis
Pericarditis
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
 
Myocarditis by Shipra Shekhar
Myocarditis by Shipra ShekharMyocarditis by Shipra Shekhar
Myocarditis by Shipra Shekhar
 
Takotsubo cardiomyopathy
Takotsubo cardiomyopathyTakotsubo cardiomyopathy
Takotsubo cardiomyopathy
 
Mitral valve stenosis
Mitral valve stenosisMitral valve stenosis
Mitral valve stenosis
 
Echocardiography in ischemic heart disease
Echocardiography in ischemic heart diseaseEchocardiography in ischemic heart disease
Echocardiography in ischemic heart disease
 
Conduction Disorders
Conduction DisordersConduction Disorders
Conduction Disorders
 
Constrictive Pericarditis
Constrictive PericarditisConstrictive Pericarditis
Constrictive Pericarditis
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated Cardiomyopathy
 

Similar to Cardiac manifestation of systemic disease.pptx final

3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx
mariaidrees3
 
Cardiac manifestation of systemic diseae.pptx
Cardiac manifestation of systemic diseae.pptxCardiac manifestation of systemic diseae.pptx
Cardiac manifestation of systemic diseae.pptx
enasfathy3
 
Ischemic and valvular heart disease
Ischemic and valvular heart diseaseIschemic and valvular heart disease
Ischemic and valvular heart disease
Milan Silwal
 
Cardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic diseaseCardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic disease
Anil Khatri
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
meducationdotnet
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
foyzur Rahman
 
systemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpointsystemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpoint
7543e80ceb
 
Pericardial Disease
Pericardial DiseasePericardial Disease
Acyanotic heart-disease
Acyanotic heart-diseaseAcyanotic heart-disease
Acyanotic heart-disease
mohammed abdulbast
 
Diagnosis and workup of restrictive cardiomyopathy.pptx
Diagnosis and workup of restrictive cardiomyopathy.pptxDiagnosis and workup of restrictive cardiomyopathy.pptx
Diagnosis and workup of restrictive cardiomyopathy.pptx
Amit Gulati
 
TB Pericarditis.pptx
TB Pericarditis.pptxTB Pericarditis.pptx
TB Pericarditis.pptx
JayBhanushali32
 
Cardiovascular system pathology
Cardiovascular system pathologyCardiovascular system pathology
Cardiovascular system pathology
Remix education
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
Biswajeeta Saha
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Sanket Nale
 
Pericardial diseases
Pericardial diseasesPericardial diseases
Pericardial diseases
Dilmo Yeldo
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
cardilogy
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
AmareDejene
 
Myocardial disease.pdf
Myocardial disease.pdfMyocardial disease.pdf
Myocardial disease.pdf
DrAliAlsaady1
 
Cardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.ppt
Cardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.pptCardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.ppt
Cardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.ppt
MesfinShifara
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
MilDoc
 

Similar to Cardiac manifestation of systemic disease.pptx final (20)

3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx3. ARRHYTHMIAS.pptx
3. ARRHYTHMIAS.pptx
 
Cardiac manifestation of systemic diseae.pptx
Cardiac manifestation of systemic diseae.pptxCardiac manifestation of systemic diseae.pptx
Cardiac manifestation of systemic diseae.pptx
 
Ischemic and valvular heart disease
Ischemic and valvular heart diseaseIschemic and valvular heart disease
Ischemic and valvular heart disease
 
Cardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic diseaseCardiovascular manifestation in systemic disease
Cardiovascular manifestation in systemic disease
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
systemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpointsystemic sclerosis and scleroderma powerpoint
systemic sclerosis and scleroderma powerpoint
 
Pericardial Disease
Pericardial DiseasePericardial Disease
Pericardial Disease
 
Acyanotic heart-disease
Acyanotic heart-diseaseAcyanotic heart-disease
Acyanotic heart-disease
 
Diagnosis and workup of restrictive cardiomyopathy.pptx
Diagnosis and workup of restrictive cardiomyopathy.pptxDiagnosis and workup of restrictive cardiomyopathy.pptx
Diagnosis and workup of restrictive cardiomyopathy.pptx
 
TB Pericarditis.pptx
TB Pericarditis.pptxTB Pericarditis.pptx
TB Pericarditis.pptx
 
Cardiovascular system pathology
Cardiovascular system pathologyCardiovascular system pathology
Cardiovascular system pathology
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Pericardial diseases
Pericardial diseasesPericardial diseases
Pericardial diseases
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
 
Myocardial disease.pdf
Myocardial disease.pdfMyocardial disease.pdf
Myocardial disease.pdf
 
Cardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.ppt
Cardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.pptCardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.ppt
Cardiomyopathy, Myocarditis and Pericarditis_C I lecture_Oct.ppt
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 

Recently uploaded

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 

Recently uploaded (20)

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 

Cardiac manifestation of systemic disease.pptx final

  • 2.  In systemic disease ,invovlement of multiple organs is the general rule.Yet cardiac involvement in many systemic diseses is not well recognise ,as the dominant manifestation frequently reside in other organ systems.Cardiac involvement is very common with many systemic disease and may account for serious morbidity or mortality.Early recognisation of cardiac involvement may impact upon patient management and prognosis.
  • 3.
  • 4.
  • 5. • Pericarditis -is the most commonly recognized cardiac problem[30%].Pericardial effusion Myocarditis –common histologically but seldom present as HF unless hypertensive.It is parallel to disease activity. Endocarditis—Fibrinous Libman Sacks endocarditis,lesion may cause embolic events or infected but rarely cause haemodynamically important regurgitation. Vascular –occlusive events as MI,CVA,TIA increase(3 TO 10 fold).More common if APLA.
  • 6. • MI—due to primarily accelerated atherosclerosis. • Riskfactors for accelerated atherosclerosis include old age,HTN,Dyslipidemia,Repeated high score disease activity, diseaseduration, high total or daily dose of glucocorticoids,postmenopausal statusand high homocysteine. • Babies born to mothers with SLEand havean increased incidence of congenital completeAV block.
  • 7. • Unexplained recurrent venous or arterial thrombosis, or frequent secondor third trimester miscarriages. • Venous thrombosis –Superficial and DVT,cerebral vein throbosis,pulmonary embolism& HTN,retinal vein thrombosis. • Arterial thrombosis—stroke,TIA,MI(10%).cardiac valve involvement or dysfunction(14%),upper and lower extremities leg ulcer ,digital gangrene and many more • Heart valve leaflet thickening, thrombotic masses extendingfrom the valve ring or leaflets, or vegetations.
  • 8.  Cardiac involvement often silent in SSc frequently detected when screened with sensitive tools as TDE,cMRI,thalium screening. Evident cardiac involvement –poor prognosis. May involve all layer ,manifest as acute pericarditis ,pericardial effusion, constrictive pericarditis, heart block or arrthymia ,ventricular dysfunction to overt HF.
  • 9. • Ventricular conduction abnormalities are common and, along with a septal pseudo-infarct pattern (q wave inversion in ecg mimic mi due to elongation and partial stretching of cardiac nerve fibres) , correlate with reduced myocardial function with exercise • Cardiac involve more in dcSSc than lcSSc and generally develop within 3yrs of onset of skin thickening
  • 10. • Most common form of chronicinflammatory polyarthritis.can involve any layers of heart. PERICARDIUM-Pericarditis-pericardial effusion(10- 40%),EXUDATIVE- Decrease Complement. • MYOCARDIUM-Rare,CMPdueto necrotising myocarditis. • ENDOCARDIUM-Coronaryarteritis,intimal inflammation present 20%,rarelymanifest. • Valveinvolvement—duetogranuloma,mitral andaorticvalve,MR
  • 11.  Associated with pancarditis and proximal AORTITIS.  Aortic involvement mainly in aortic root but may extent upto aortic and mitral valve,ventricular myocardium.  1/10 significant AR and 1/3 present with conduction block (even CHB)  AR may precedes onset of arthritis ,SO DX OF SERONEGETIVE ARTHRITIS SHOULD BE CONSIDERED IN YOUNG MALE WITH ISOLATED AR
  • 12. • Granulomatous inflammatory diseaseof unknown cause. • Pericarditis though uncommon –usually clinically insignificant • Granulomatous infiltrative diseaseof the myocardium is often asymptomatic, but can causearrhythmias, conduction diseaseand, rarely, otherwise unexplained congestive heart failure
  • 13. • Pulmonary artery hypertension and cor pulmonale canoccur in sarcoidosis,generally asaresult of pulmonary fibrosis. • Systemicvasculitis - anuncommon complication of sarcoidosis. • Sarcoidvasculitis canaffect small- to large- caliber vessels,including the aorta.
  • 14.
  • 15. CAD is the most common causeof death in adults with DM. • DM, is an independent risk factor for CAD and accounts for 14–50% of new casesof cardiovasculardisease. • Pathogenesis- • endothelial dysfunction • increased lipoprotein peroxidation • increased inflammation, • aprothrombotic state, • associated metabolic abnormalities.
  • 16.
  • 17. Diabetic patients aremore likely to have MI ,greater burden of CAD, larger infarct size, more post infarct complications( HF, shock,death). •.“SILENT ISCHEMIA,”resulting from ANS dysfunction, accounting for up to 90%of their ischemic events. •ATYPICALischemic symptoms- nausea,dyspnea,arrthymias,pulmonaryedema,heart block,syncope—ANGINALEquivalent
  • 18. Patients with DM also may have • Abnormal LV systolic anddiastolic function, reflecting concomitant hypertension, Coronary microvascular disease, • Endothelial dysfunction, • Ventricular hypertrophy, • Autonomic dysfunction. • Restrictive cardiomyopathy • INSULIN THERAPY MAY DECREASE OVERALL MYOCARDIAL DYSFUNCTION.
  • 19.
  • 20.  Bp is altered across the entire spectrum thyroid function.  HYPERTHYROID ISM:- Widened pulse pressure arterial stiffness ISOLATED SYS HTN low systemic VR HYPOTHYROIDISM:- Endothelial dysfunction Impaired VSM relaxation Diastolic HTN
  • 21.  INCREASES in – heart rate – cardiac contractility, – systolic and mean pulmonary artery pressure, – cardiac output, diastolic relaxation, and – myocardial oxygen consumption  REDUCTIONS in – systemic vascular resistance and – diastolic pressure
  • 22. Tachycardia, at rest, during sleep, and exaggerated during exercise. • Palpitations – tachy/forceful cardiac contractility • Hyperdynamic precordium. • Systolic hypertension with widened pulse pressure • Exertional dyspnea, which is due to respiratory and skeletal muscle weakness
  • 23. • Uncommon heart murmur which occurs in patients with hyperthyroidism. • It is a mid-systolic scratching sound best heard over the second left intercostal space at the end of expiration. • Results from the rubbing of the pericardium against the pleura in the context of hyperdynamic circulation and tachycardia, • Mimic the sound of a pericardial rub.
  • 24.
  • 25.  Major cardiovascular changes – decrease in cardiac output – decrease in cardiac contractility – reduction in heart rate – increase in peripheral vascular resistance.  • Others – Hypercholesterolemia , – diastolic hypertension, carotid intimal media thickness
  • 26. • Exertional dyspnea • Cardiac dysfunction with poor contractility. • Bradycardia. Pericardial effusions, in approximately 25% of patients and may be quite large. •Increased systemic capillary permeability and disturbances in electrolyte metabolism. • characterized by a high protein and cholesterol content.
  • 27.  – Hypercholesterolemia  – Diastolic hypertension, and  – Elevated homocysteine levels  – Elevated C-reactive protein and  – Endothelial dysfunction • Patients with angina pectoris probably have less symptoms as they are less active and peripheral oxygen demands decrease.
  • 28. • Exposureof the heart toexcessivegrowth hormone may causeCHFasaresult of high cardiac output, diastolic dysfunction owing to ventricular hypertrophy global systolicdysfunction. • Hypertension occurs in up to one-third of patients with acromegaly and is characterized by suppression of the renin-angiotensin-aldosterone axisand increases in total-body sodium andplasma volume. • Some form of cardiac disease occurs in about one- third of patients with acromegaly and is associated with adoubling of the risk of cardiac death.
  • 29. • In addition to causing labile or sustained hypertension, the high circulating levels of catecholamines resulting from a pheochromocytoma may causedirect myocardial injury. • Focalmyocardial necrosis and inflammatory cell infiltration are present in ~50%of patients whodie with pheochromocytoma and may contribute to clinically significant left ventricular failure and pulmonary edema. • Left ventricular dysfunction and CHFmay resolve after removal of thetumor.
  • 30.
  • 31.  The pulseless disease or occlusive thromboaortopathy.  Aneurysm most common and clinically most significant in aortic root where they can lead to valvular regurgitation(aprox 20%)
  • 32. • Causeof GCAremains unknown, the inflammatory lesion begins in theadventitia. • Most characteristic features of GCAare new onset of atypical and often severe headaches, scalp and temporal artery tenderness, acute visual loss, polymyalgia rheumatica, and painin the muscles of mastication. • GCAmay produce clinically apparent aortitisin ~15%of casesand involve the primarybranches of the aorta, especially thesubclavian arteries,
  • 33. • Raresyndrome that includes ahistory of asthma, eosinophilia, pulmonary infiltrates, upper airway inflammation, and avariable frequency of renal, neurological, cutaneous, and cardiac involvement. • Cardiacdiseasein CSSis the most commoncause of death. It is reported in 15 to 55 percent of casesand may include pericarditis, myocarditis, and coronary arteritis. Congestive heart failure occurs in 15 to 30 percent ofcases.
  • 34. • Nongranulomatous disease of onlymedium- sized arteries. • Necrotizing changesseen, with weakening of the vesselwall and aneurysm formation or myointimal proliferation, causingstenosisand occlusion. • cardiac disease(10 to 30 percent; congestive failure, angina, infarction, pericarditis) hypertension (approximately 30 percent)
  • 35. • Acute febrile systemic illness of childhood. • Cardiacabnormalities - pericardial effusions (~30 %),myocarditis, mitral regurgitation (~ 30 %), aortitis and aortic regurgitation (infrequent), congestive heart failure, and atrial andventricular arrhythmias. • Deaths usually result from acute coronaryartery thrombosis in aneurysms that form following vasculitis.
  • 36.
  • 37. • Thiamine deficiency hasbeen found in 20–90% of patients with chronic heart failure. This deficiency appears to result from both reduced dietary intake and adiuretic-induced increase in the urinary excretion ofthiamine. • The acute administration of thiamine to these patients increases the left ventricular ejection fraction and the excretion of saltand water. • The classic associated cardiovascular syndrome is characterized by high-output heart failure, tachycardia, and often elevated biventricular filling pressures
  • 38. • In patients whose intake of protein,calories, or both is severely deficient, the heart may become thin, pale, and hypokinetic with myofibrillar atrophy and interstitial edema. • Generalized edema is common and relates to a variety of factors, including reduced serum oncotic pressure and myocardialdysfunction. • Open-heart surgery posesincreased risk in malnourished patients.
  • 39. • 50%of patients with carcinoid syndrome havecardiac involvement, usually manifesting asabnormalities of the tricuspid or pulmonic valves. • Carcinoid heart diseasemost often presents as tricuspid regurgitation, pulmonic stenosis, or both. In some cases,ahigh cardiac output state may occur, presumably asaresult of a decrease in systemic vascular resistance resulting from vasoactive substancesreleased by the tumor
  • 40. • Obesity is associated with an increased prevalence of hypertension, glucose intolerance, atherosclerotic CAD,atrial fibrillation, obstructive sleep apnea, and pulmonary hypertension, and is associated with increased cardiovascular morbidity and mortality rates. • In addition, obesepatients haveadistinct hemodynamic profile characterized by increased total and central bloodvolumes, increased cardiac output, and elevatedleft ventricular filling pressure
  • 41. • In part asaresult of chronic volume overload, eccentric cardiac hypertrophy with cardiac dilation and ventricular diastolic and/or systolicdysfunction may develop. • In addition, altered levels of adipokines secretedby adipose tissue may contribute to adverse myocardial remodeling via direct effects on cardiac myocytes and other cells.